Article info
PDFCommentary
We must tell our patients what is wrong with them even if we don't know why they have symptoms
- Correspondence to Dr J Stone, Consultant Neurologist and Honorary Senior Lecturer, Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Crewe Rd, Edinburgh EH4 2XU, UK; Jon.Stone{at}ed.ac.uk
Citation
We must tell our patients what is wrong with them even if we don't know why they have symptoms
Publication history
- First published March 8, 2011.
Online issue publication
April 14, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies
- Stress and functional neurological disorders: mechanistic insights
- Can stress trigger Parkinson's disease?
- Functional neurological disorder is a feminist issue
- ‘Undiagnosing’ neurological disease: how to do it, and when not to
- Proceedings of the Association of British Neurologists, University of Oxford, 3 April – 5 April 2002
- CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
- Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study
- Characterising the gut microbiome in veterans with Gulf War Illness: a protocol for a longitudinal, prospective cohort study
- Decade of progress in motor functional neurological disorder: continuing the momentum